NFKB1 and gastric cancer: Follow‐up investigations further confirmed that excess CAFs‐mediated secretion led to enhanced serum IL‐8 levels, which, in turn, activated the NF‐κB axis, thereby enhancing the tumour cell resistance gene ABCB1 expression, thus ultimately inducing cisplatin resistance against gastric cancer.16